Teikoku Tsushin Kogyo announces share buyback plan
Teikoku Tsushin Kogyo’s buyback plan is designed to enhance shareholder value by repurchasing up to 150,000 shares, or 1.6% of its outstanding shares, at a total cost of 300 million yen.
Stay updated with the latest news and articles about capital management.
Teikoku Tsushin Kogyo’s buyback plan is designed to enhance shareholder value by repurchasing up to 150,000 shares, or 1.6% of its outstanding shares, at a total cost of 300 million yen.
Shanghai Fosun Pharmaceutical has approved the repurchase and cancellation of over 1 million restricted shares for approximately 22.8 million yuan. The move will reduce the company's issued share capital to 2,671,326,465 shares and its registered capital by 1.1 million yuan.